Delivery Order SPE2DR25D1100-SPE2DR26FCN4A
- Not listed
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Eliquis 5 mg tablets (60-count packaging) valued at $12,260.04. This is a firm fixed-price delivery order with no set-aside designation, executed under competitive procedures. The order is scheduled for completion by May 13, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Eliquis is an anticoagulant...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Eliquis 5 mg tablets (60-count units) valued at $12,612.95. This non-competitive, firm fixed-price delivery order is expected to be completed by August 19, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. Eliquis is an anticoagulant medication commonly used in military and veteran healthcare settings for stroke prevention and blood clot...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 11, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) valued at $9,066.65. This firm fixed-price delivery order, with an ultimate completion date of June 12, 2025, represents a non-set-aside competitive award and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. Eliquis is a widely prescribed anticoagulant medication used in military and veteran...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg on November 5, 2025, with a ceiling value of $6,624.83. This is a firm fixed-price delivery order with no set-aside designation, issued under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of November 6, 2025....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) with a contract ceiling value of $5,424.25. This firm fixed-price delivery order, which has an ultimate completion date of November 3, 2025, was competitively awarded without set-aside provisions and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Eliquis is a widely-used...
- The Defense Logistics Agency awarded a delivery order valued at $44,263.82 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages) on September 9, 2025, with completion expected by September 10, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Eliquis is a brand-name anticoagulant medication commonly used in...
- The Defense Logistics Agency awarded a $36,587.93 delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on July 28, 2025, with completion scheduled for July 29, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contractor, headquartered in Conshohocken, Pennsylvania, will perform all work...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Eliquis 5 mg tablets (60-count units) with a contract ceiling value of $14,301.29. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The order is scheduled for completion by September 23, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. Eliquis is...
- The Defense Logistics Agency awarded a delivery order valued at $17,793.41 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on July 14, 2025, with an ultimate completion date of July 15, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Eliquis is an anticoagulant medication used in military and federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Eliquis 5 mg tablets in quantities of 60 units, with a ceiling value of $15,724.80. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is due for completion by September 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Eliquis is an...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FCN4ADelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Eliquis 5 mg tablets (60-count units) at a ceiling value of $15,659.94. This is a firm fixed-price delivery order with no set-aside designation, executed through open competition. The order is set for ultimate completion by November 10, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. Eliquis is a branded anticoagulant medication commonly used in military and veteran healthcare systems to prevent blood clots and reduce stroke risk. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.999 billion prime contract vehicle running through December 2026 that serves as a comprehensive global pharmaceutical support platform. Through this contract, AmerisourceBergen supplies a diverse portfolio of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, vaccines, and medical devices across multiple therapeutic domains. The company's role as a pharmaceutical prime vendor enables it to serve the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, positioning it as a critical supplier within the military medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.7k | 11/7/25 |